Ngā hua rapu - David Altmann
- E whakaatu ana i te 1 - 3 hua o te 3
-
1
The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality mā D. A. M. J. Theuns, Beat Schaer, Osama Soliman, David Altmann, Christian Sticherling, Marcel L. Geleijnse, S Osswald, Luc Jordaens
I whakaputaina 2010Artigo -
2
Elevated Cardiac Troponin I in Sepsis and Septic Shock: No Evidence for Thrombus Associated Myocardial Necrosis mā David Altmann, Wolfgang Korte, Micha T. Maeder, Thomas Fehr, Philipp K. Haager, Hans Rickli, Gian‐Reto Kleger, Regulo Rodriguez, Peter Ammann
I whakaputaina 2010Artigo -
3
Individually tailored vs. standardized substrate modification during radiofrequency catheter ablation for atrial fibrillation: a randomized study mā Simon Kircher, Arash Arya, David Altmann, Sascha Rolf, Andreas Bollmann, Philipp Sommer, Nikolaos Dagres, Sergio Richter, Ole A. Breithardt, Borislav Dinov, Daniela Husser, Charlotte Eitel, Thomas Gaspar, Christopher Piorkowski, Gerhard Hindricks
I whakaputaina 2017Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Cardiology
Internal medicine
Medicine
Myocardial infarction
Ablation
Anesthesia
Atrial fibrillation
Cardiac resynchronization therapy
Catheter ablation
Clinical endpoint
Coagulation
Comorbidity
Confidence interval
Defibrillation
Ejection fraction
Environmental health
Fibrin
Hazard ratio
Heart failure
Immunology
Implantable cardioverter-defibrillator
Population
Proportional hazards model
Pulmonary vein
Randomized controlled trial
Sepsis
Septic shock
Shock (circulatory)
Sinus rhythm
Systemic inflammatory response syndrome